Thermo Fisher Scientific Patents

Patent portfolio assigned to Thermo Fisher Scientific (verified via public assignee records). Life-sciences/lab instruments company. Partners: Pfizer (NGS-based cancer testing collaboration, May 2023); Broad Institute (Thermo Fisher licensed CRISPR IP from Broad). Many patents via Thermo Fisher Scientific entities as assignee (e.g. US20120283311A1, US7574929B2 controllable pipette).